Publications

Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE) is a cognitive-behavioral psychotherapy program designed for patients who have posttraumatic stress disorder (PTSD) and a co-occurring alcohol or drug use disorder. COPE represents an integration of two evidence-based treatments: Prolonged Exposure (PE) therapy for PTSD and Relapse Prevention for substance use disorders.

Summary

Canada’s Low-Risk Alcohol Drinking Guidelines were originally published by CCSA in November 2011 and were the result of the work of alcohol research experts in Canada.

The European Web Survey on Drugs1 collected data during March and May 2021 from people who use drugs, are aged 18 or older, and live in 21 EU and 9 non-EU countries including Lebanon. In this period, the populations in many European and neighbouring countries were experiencing COVID-19-related lockdown or restrictions.

Today’s youth face many risks, including drug abuse, violence, and HIV/AIDS. Responding to these risks before they become problems can be difficult. One of the goals of the National Institute on Drug Abuse (NIDA) is to help the public understand the causes of drug abuse and to prevent its onset. Drug abuse has serious consequences in our homes, schools, and communities.

This volume emerged from the 25th International Week at Frankfurt University of Applied Sciences. The contributions it contains are based on papers that examine social work in the areas of drug use and treatment, HIV/AIDS and other infectious diseases, and social work in prisons. They cover aspects of the history and international development of social work, plus drug policy and practice.

Central Asia (CA) and China are key regions in terms of international efforts to tackle illicit drug trafficking and the problems related to it such as addiction. Modern and effective approaches to treating drug use disorders, according to the UN/WHO International Treatment Standards, exist in all countries but lack institutionalisation and require further expansion and harmonisation.

Estimadas y estimados colegas de ISSUP,

Los invitamos a consultar la  Revista Internacional de Investigación en Adicciones (RIIAD). En esta edición encontrarán artículos como “Una mirada a la genética y epigenética en adicción a sustancias”, “Viso-construcción y memoria visual en jóvenes con dependencia a las metanfetaminas”, entre otros.

Knowledge, Attitudes, and Practice towards Alcohol Use and its Related Factors among Regular Users
Kashif Kamran Khan, Amber Shahzadi
EQUIP Research & Development Consultants

Substance use and mental health needs are two of the primary concerns for many people experiencing multiple disadvantage. We know that people who experience both issues at the same time (also known as “co-occurring conditions” or “dual diagnosis”) find it difficult or impossible to access the right support for their needs.

This factsheet summarises information and statistics on new psychoactive substances gathered from recent reports on prevalence, treatment, mortality and legislation in Ireland.

Between March and May 2021, the EU4Monitoring Drugs (EU4MD) project supported the mapping of national prevention systems in European Neighbourhood Policy (ENP) area countries.

This briefing describes the rationale and methodology of the prevention system mapping, presenting selected findings and highlighting key challenges encountered.

Download as PDF 

In this blog post and guide, Dr. Stephen Parkin shares his observations about the use of stigmatising words and phrases in academic writing, and offers a list of person-centred and pragmatic alternatives.

At the start of may 2022 the Preventive Education and Training Unit of the National Dangerous Drugs Control Board has conducted  training on Universal Treatment Curriculum, Course 01 (UTC - 01) for 32 staff members in NDDCB.

This document provides guidance on the clinical management of harms resulting from acute intoxication and from the harmful and dependent use of club drugs and Novel Psychoactive Substances (NPS). 

Handbook of Novel Psychoactive Substances (NPS) provides a comprehensive overview of the challenges that clinicians face when dealing with NPS and discusses how the profile of patients and their socio-demographic characteristics frame the serious public health concern that NPS pose.

In light of the recent emergence of Novel Psychoactive Substances (NPS) on a global scale, this book provides a timely analysis of the social and economic impact of the NPS phenomenon, and of the global policy and regulatory responses to it.

Executive summary

The 10-year UK Government plan to combat illegal drugs sets out how we are doing more than ever to cut off the supply of drugs by criminal gangs and give people with a drug addiction a route to a productive and drug-free life. Underpinned by record investment of over £3 billion in the next three years, we will reduce drug-related crime, death, harm and overall drug use.

About the Report

​Addiction Policy Forum’s (APF) Patient Experiences Journey Map was developed through the input of patients in treatment and recovery from substance use disorder (SUD). The map underscores the obstacles and positive points patients encounter across seven distinct phases, from treatment to finding long-term, stable recovery.​

Ponemos a su disposición el número más reciente de la Revista CIJ Informa, donde encontrarán una sección dedicada a noticias internacionales. En esta ocasión, hablamos de la participación de CIJ en la presentación del Informe 2021 de la Junta Internacional de Fiscalización de Estupefacientes (JIFE).